To the Editor
We have read with interest the study of Slob et al 1 recently published in your journal. This retrospective study was designed to investigate the usefulness of Color-Duplex Doppler Sonography (CDS) as a first vascular screening in the diagnostic workup of impotent men. Results of psychophysiological diagnostic screening (PDS) and CDS testing were compared in a cohort of 44 men. They found that in more than 50% of patients diagnosed as having psychogenic ED on PDS screening, CDS testing revealed a vascular 'abnormality'. They concluded that CDS represents an inadequate screening test in ED patients, because of the high rate of false-positive diagnosis of 'vasculogenic incompetence' in patients with psychogenic ED.
In the diagnosis of vasculogenic ED, Slob et al 1 wish to evaluate CDS accuracy by using the response to PDS as a gold standard. However, in their experimental design, the PDS-diagnosis of 'psychogenic ED' was based mainly upon the finding that a valid-for-intromission erection was obtained during the ICI testing. In the clinical evaluation of erection after ICI testing, we have recently demonstrated that a positive responseFthat is, semirigid or rigid erection attainedFis frequently associated with the presence of vascular abnormalities as detected by CDS. 2 In our series of 195 patients, it was emphasized that those who showed a semirigid erection, which is a functional erection, were then diagnosed as having arterial (20%), veno-occlusive (37%) or mixed (6%) ED by CDS studies. We concluded that ICI alone may be a misleading diagnostic test to exclude vascular ED, since a consistent subset of patients may be given an incorrect diagnosis of 'psychogenic ED'. Along this view, the series of psychogenic ED by Slob et al, may be classified as patients with 'minimal vasculogenic ED' who exhibit a good pharmacological erection: this leads to a different (opposite) interpretation of their data.
We fully agree with the authors that in the era of orally active agents, CDS may not be considered a necessary first screening for all ED patients; however, there are several important issues to be taken into account. (1) Recent consensus meeting statements claimed that the differential diagnosis of ED patients remains mandatory in good medical practice. 3 (2) Patients referred to the specialist are increasingly those who do not respond to orally active drugs and seek for an explanation as to why these agents failed. (3) The mean age of ED patients is often above 55 y with frequent co-morbidities such as cardiovascular disease as demonstrated by epidemiological studies; 4 in these patients, ED may be the first presenting symptom of a multiorgan vascular dysfunction requiring extensive investigation and treatment. (4) CDS studies may measure improvements in the compliance of cavernous arteries in patients treated with ICI and/or longacting oral PDE-5 inhibitors. 5 (5) Finally, in the near future differential diagnosis will be necessary to redirect patients to selective treatment plans. 2 In conclusion, in our opinion CDS remains a useful and accurate diagnostic screening procedure especially in those ED patients who have a significant risk of cardiovascular disease or a prior failure to conventional therapies. 
